Does the mechanism and severity of severe tricuspid regurgitation affect the risk of death and heart failure readmission?
Massive/torrential tricuspid regurgitation and pulmonary comorbidities identify patients at high risk for death and heart failure readmission, highlighting the need for careful clinical assessment and potential intervention.
Patients with massive/torrential TR and patients with comorbidities, especially pulmonary disease, were identified as populations at higher risk of death and readmission for HF. New classification scheme and clinical assessment may establish who may benefit the most of intensive therapeutic treatments and intervention on the tricuspid valve.
Santoro et al. (Mon,) studied this question.